Nomination committee appointed

As per specifications set at Meda’s 2015 annual general meeting, a nomination committee has been appointed. It consists of:

Bert Åke Eriksson, Committee Chairman, Stena Sessan Rederi AB

Sigieri Diaz Pallavicini, Fidim S.r.l.

Evert Carlsson, Swedbank Robur Funds

Elisabet Jamal Bergström, Handelsbanken Fonder

Martin Svalstedt, Meda’s Chairman of the Board

For further inquiries, please contact:

Paula Treutiger, VP Corporate Communications & Sustainability                                     ph: +46 733-666 599                                                                                                                                                                                                        

MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.